271 related articles for article (PubMed ID: 27542253)
1. Luminal B breast cancer: patterns of recurrence and clinical outcome.
Li ZH; Hu PH; Tu JH; Yu NS
Oncotarget; 2016 Oct; 7(40):65024-65033. PubMed ID: 27542253
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
4. Patterns of recurrence and outcomes in patients with luminal breast cancer: a retrospective study.
Li ZH; Xiong JP; Hu PH; Tu JH
Eur J Gynaecol Oncol; 2017; 38(1):14-19. PubMed ID: 29767858
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
6. Patterns of breast cancer relapse in accordance to biological subtype.
Ignatov A; Eggemann H; Burger E; Ignatov T
J Cancer Res Clin Oncol; 2018 Jul; 144(7):1347-1355. PubMed ID: 29675790
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia.
Anwar SL; Avanti WS; Nugroho AC; Choridah L; Dwianingsih EK; Harahap WA; Aryandono T; Wulaningsih W
World J Surg Oncol; 2020 May; 18(1):117. PubMed ID: 32473643
[TBL] [Abstract][Full Text] [Related]
8. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological features and prognosis of HER2-negative luminal-type breast cancer patients with early and late recurrence].
Chen XL; Fan Y; Xu BH
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):448-53. PubMed ID: 27346403
[TBL] [Abstract][Full Text] [Related]
10. Pattern of distant metastasis in molecular subtypes of carcinoma breast: An institutional study.
Kunikullaya SU; Poddar J; Sharma AD; Patel S
Indian J Cancer; 2017; 54(1):327-332. PubMed ID: 29199716
[TBL] [Abstract][Full Text] [Related]
11. Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab.
McGuire A; Kalinina O; Holian E; Curran C; Malone CA; McLaughlin R; Lowery A; Brown JAL; Kerin MJ
Breast Cancer Res Treat; 2017 Jul; 164(1):221-229. PubMed ID: 28378298
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and recurrence patterns according to breast cancer subtypes in Korean women.
Lee Y; Kang E; Lee AS; Baek H; Kim EK; Park SY; Kim JH; Kim YJ; Kim SH; Kim IA; Eom KY; Kim SW
Breast Cancer Res Treat; 2015 May; 151(1):183-90. PubMed ID: 25893592
[TBL] [Abstract][Full Text] [Related]
13. Outcomes by molecular subtype after accelerated partial breast irradiation using single-entry catheters.
Saini A; Kuske R; Quiet C; Pantoja C; Reed D; Zannis V
Brachytherapy; 2018; 17(2):415-424. PubMed ID: 29146102
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.
Wang Y; Yin Q; Yu Q; Zhang J; Liu Z; Wang S; Lv S; Niu Y
Breast Cancer Res Treat; 2011 Nov; 130(2):489-98. PubMed ID: 21837481
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and prognosis of different subtypes of breast cancer].
Yuan ZY; Wang SS; Zhu MQ; Zheng L; Luo WB; Zhou ZM; Guan ZZ
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):456-61. PubMed ID: 19024523
[TBL] [Abstract][Full Text] [Related]
16. Follow-up of patients with localized breast cancer and first indicators of advanced breast cancer recurrence: A retrospective study.
Viot J; Bachour M; Meurisse A; Pivot X; Fiteni F
Breast; 2017 Aug; 34():53-57. PubMed ID: 28505557
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
[TBL] [Abstract][Full Text] [Related]
18. Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes.
Kos T; Aksoy S; Sendur MA; Arik Z; Civelek B; Kandemir N; Ozdemir NY; Zengin N; Altundag K
J BUON; 2013; 18(3):608-13. PubMed ID: 24065471
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
[TBL] [Abstract][Full Text] [Related]
20. Locoregional recurrence by molecular subtype after multicatheter interstitial accelerated partial breast irradiation: Results from the Pooled Registry Of Multicatheter Interstitial Sites research group.
Anderson BM; Kamrava M; Wang PC; Chen P; Demanes DJ; Hayes JK; Kuske RR
Brachytherapy; 2016; 15(6):788-795. PubMed ID: 27743957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]